Randomised phase-II trial of CAPIRI (capecitabine, irinotecan) plus bevacizumab vs FOLFIRI (folinic acid, 5-fluorouracil, irinotecan) plus bevacizumab as first-line treatment of patients with unresectable/metastatic colorectal cancer (mCRC)
2012 ◽
Vol 106
(3)
◽
pp. 453-459
◽
J Souglakos
◽
N Ziras
◽
S Kakolyris
◽
I Boukovinas
◽
N Kentepozidis
◽
...
2008 ◽
Vol 26
(15_suppl)
◽
pp. 15064-15064
H. Albrecht
◽
A. Wein
◽
K. Wolff
◽
V. Brueckl
◽
C. Meier
◽
...
H Albrecht
◽
A Wein
◽
C Meier
◽
N Ostermeier
◽
V Brueckl
◽
...
2011 ◽
Vol 16
(11)
◽
pp. 1557-1564
◽
Eric Assenat
◽
Francoise Desseigne
◽
Simon Thezenas
◽
Frédéric Viret
◽
Laurent Mineur
◽
...
2007 ◽
Vol 73
(1-2)
◽
pp. 9-20
◽
Craig Underhill
◽
David Goldstein
◽
Vera A. Gorbounova
◽
Mikhail Y. Biakhov
◽
Igor S. Bazin
◽
...
2018 ◽
Vol 23
(8)
◽
pp. 919-927
◽
Goro Nakayama
◽
Ayako Mitsuma
◽
Yuki Sunagawa
◽
Kiyoshi Ishigure
◽
Hiroyuki Yokoyama
◽
...
2005 ◽
Vol 16
(2)
◽
pp. 282-288
◽
M.M. Borner
◽
J. Bernhard
◽
D. Dietrich
◽
R. Popescu
◽
M. Wernli
◽
...
2018 ◽
Vol 29
◽
pp. viii202
A. De Stefano
◽
G. Nasti
◽
A. Febbraro
◽
G. Rosati
◽
F. Giuliani
◽
...
2015 ◽
Vol 51
(8)
◽
pp. 942-949
◽
Guillem Argilés
◽
Mark P. Saunders
◽
Fernando Rivera
◽
Alberto Sobrero
◽
Al Benson
◽
...
2005 ◽
Vol 23
(16_suppl)
◽
pp. 3540-3540
P. Garcia-Alfonso
◽
G. Perez-Manga
◽
M. C. Gonzalez
◽
P. Lopez
◽
E. Gonzalez
◽
...
Close
Export Citation Format
Close
Share Document
Close